Hearing on “Examining Implementation of the Compounding Quality Act,” Subcommittee on Health (January 30, 2018)
The Subcommittee on Health held a hearing on Tuesday, January 30, 2018, at 11:00 a.m. in 2123 Rayburn House Office Building. The hearing is entitled “Examining Implementation of the Compounding Quality Act.”
Livestream
Key Documents
Memorandum from Ranking Member Pallone to the Subcommittee on Health
Opening Statement of Ranking Member Pallone as prepared for delivery
Opening Statement of Subcommittee Ranking Member Green as prepared for delivery
Witnesses
Panel I:
Scott Gottlieb, M.D.
Commissioner
U.S. Food and Drug Administration
Panel II:
Jenn Adams
Senior Vice President and President, Clinical Product Solutions
PharMEDium Services
Bruce A. Brod, M.D., FAAD
Chair, Congressional Policy Committee
American Academy of Dermatology Association
Nancy Dargan
Patient of New England Compounding Center
Shawn E. Hodges, PharmD
Pharmacist and Vice President
International Academy of Compounding Pharmacists
Elizabeth Jungman
Director, Public Health
The Pew Charitable Trusts
Jacob Olson, PharmD, R.Ph
President and CEO
Skywalk Pharmacy on behalf of National Community Pharmacists Association
Molly Ventrelli
Vice President, Regulatory Affairs
Fresenius Kabi
George Williams, M.D.
President Elect
American Academy of Ophthalmology